Has Yousif Arahim, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,744 in general payments to Yousif Arahim, MD across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yousif Arahim, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yousif Arahim, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yousif Arahim, MD

Gastroenterology · Aiea, HINPI 1740213990

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,058 of the $10,744 with a category attached, or 75.0%. Medtronic accounts for 91.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $9,735 and has fallen 98.5% since, to $145 in 2025.

$10,744in general payments, 2019–2025

Across 39 payments — averaging $275.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$10K
Boston Scientific$697
AbbVie$135
Takeda Pharmaceuticals U.S.A., Inc.$47
Redhill Biopharma Inc.$19
Celltrion USA Inc.$16

What the payments were for

Consulting fees$8,05875%
Travel & lodging$1,14711%
Food & beverage$1,53914%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	11	$9,829
Boston Scientific	18	$697
AbbVie	6	$135
Takeda Pharmaceuticals U.S.A., Inc.	2	$47
Redhill Biopharma Inc.	1	$19
Celltrion USA Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GI Genius$8,523
OverStitch Endoscopic Suturing System$109

How this compares

$10,744 in reported general payments places this provider in the 85th percentile of 71 gastroenterology providers in Hawaii.

See all gastroenterology providers in Hawaii →

Medicare billing

Part B allowed, 2024

$58,928

Medicare patients

167

Services billed

477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	79	$1,186
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	30	$533

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Aiea

Aaron SmallAiea$20K
Robert WongAiea$2K
Darrell LeeAiea$1K
Tesu LinAiea$771
Naoky TsaiKailua$587K
Russell YangHonolulu$244K
Roland TerHonolulu$37K
Robert JaoKailua$28K
Shelini SooklalWailuku$21K
Daniel ChanEwa Beach$17K

See the full list for Hawaii →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →